Allergan puts Vraylar on blockbuster track with new bipolar depression nod

28th May 2019 Uncategorised 0

Allergan, badly in need of good news, finally has some to share. On Tuesday, the FDA greenlighted the company’s Vraylar to treat bipolar depression, a key piece of its bid for billion-dollar sales.

More: Allergan puts Vraylar on blockbuster track with new bipolar depression nod
Source: fierce